午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

武漢敬康恩生物醫(yī)藥科技有限公司 公司信息

公司名稱: 武漢敬康恩生物醫(yī)藥科技有限公司
電話: 13720134139 086-15871494362
電子郵件:orders@jknbiochem.com
國籍:中國
網(wǎng)址: https://www.jknbiochem.com
產(chǎn)品總數(shù):6204

公司提供產(chǎn)品列表

Ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate 161798-02-3
ApreMilast 608141-41-9
Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate 161798-03-4
Febuxostat 非布司他 144060-53-7
Ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate 161797-99-5
Abemaciclib 1231929-97-7
Lambrolizumab 1374853-91-4
Siltuximab 541502-14-1
EFALIZUMABUM 214745-43-4
Gemtuzumab 220578-59-6
Naptumomab Estafenatox 676258-98-3
Erlotinib Hydrochloride 183321-74-6
(4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one 189028-95-3
Entecavir hydrate 209216-23-9
(R)-(-)-2,2-dimethyl-1,3-dioxolane-4-methanol 14347-78-5
Diisopropylamine dichloroacetate 660-27-5
Ezetimibe 依折麥布 163222-33-1
(S)-1-(4-Fluorophenyl)-5-(2-oxo-4-phenyloxazolidin-3-yl)pentane-1,5-dione 189028-93-1
Eculizumab 219685-50-4
Apalutamide 阿帕魯胺 956104-40-8
Ibrutinib (PCI-32765) 依魯替尼 936563-96-1
Crisaborole 克立硼羅 906673-24-3
Topiroxostat 577778-58-6
Neratinib 688387-09-6
Carbazochrome Sodium Sulfonate 51460-26-5
NEW PRODUCTS INTRODUCTION
Pomalidomide 19171-19-8
4,4-dimethyl-3,5,8- trioxabicyclo[5.1.0]octane 57280-22-5
Bevacizumab 216974-75-3
Olaparib 奧拉帕尼 763113-22-0
Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate 160844-75-7
Ethyl 2-(3-formyl-4- hydroxyphenyl)-4- methylthiazole-5-carboxylate 161798-01-2
palivizumab 188039-54-5
Siplizumab 288392-69-8
Amatuximab 931402-35-6
Omalizumab 242138-07-4
Natalizumab 189261-10-7
4-hydroxythiobenzamide 25984-63-8
Nivolumab 946414-94-4
Gevokizumab 1129435-60-4
Biciromab 138783-13-8
Satumomab 144058-40-2
Imciromab 126132-83-0
Arcitumomab 154361-48-5
Rafivirumab 944548-37-2
Ixekizumab 1143503-69-8
dupilumab 1190264-60-8
Sarilumab 1189541-98-7
Dacliximab 152923-56-3
Vonoprazan 881681-00-1
1-Methylcyclopropanecarboxylic acid 6914-76-7
Research Grade Cedelizumab 156586-90-2
Narsoplimab 2108782-45-0
Lorvotuzumab Mertansine 1008106-64-6
Alemtuzumab 216503-57-0
Research Grade Fontolizumab 326859-36-3
Ruplizumab 220651-94-5
Visilizumab 219716-33-3
nimotuzumab 828933-51-3
cantuzumab mertansine 400010-39-1
Matuzumab 339186-68-4
Lymphocide 205923-57-5
TocilizuMab 375823-41-9
Ranibizumab 347396-82-1
Iodine (131I) Derlotuximab Biotin 340013-96-9
Research Grade cT84.66
Tositumomab 208921-02-2
Tadocizumab 339086-80-5
Pascolizumab 331243-22-2
Oregovomab 213327-37-8
Gavilimomab 244096-20-6
Foravirumab 944548-38-3
Milatuzumab 899796-83-9
mepolizumab 196078-29-2
Edrecolomab 156586-89-9
Research Grade Afelimomab 156227-98-4
Research Grade Cc49
Research Grade T10B9.1A-31
Enlimomab 142864-19-5
Inolimomab 152981-31-2
Odulimomab 159445-64-4
Edobacomab 141410-98-2
Sulesomab 167747-19-5
Basiliximab 179045-86-4
Abciximab 143653-53-6
Lintuzumab 166089-32-3
Pexelizumab 219685-93-5
Igovomab 171656-50-1
Sevirumab
Research Grade Tecnemab
Labetuzumab 219649-07-7
Motavizumab 677010-34-3
Abagovomab 792921-10-9
Nofetumomab 165942-79-0
Research Grade Immurait-Ll2Mab
Hu1D10 267227-08-7
Mitumomab 216503-58-1
Capromab 145464-28-4
Pertuzumab 帕妥珠單抗 380610-27-5
Bavituximab 648904-28-3
Copyright 2007? ChemicalBook. All rights reserved.